Sourcing and Distribution of unlicensed medicines globally, to regions where a product is not commercially available, responding to market demand for medicines. A resource for Hospitals, Pharmacies and Health Care Professionals (HCPs)
Key Features:
- Access to 1000’s of unlicensed medicines from all around the world, ethically-sourced from our global network of qualified and verified suppliers
- Unrivalled sourcing capabilities, with direct relationships with Specialty Manufacturers
- Global supply chain & Logistics capabilities, with the ability to deliver to 120+ countries worldwide
- In-House Quality and Regulatory expertise
- Ability to source and manage large quantities to tackle global shortages
- Customer Service who are multi-lingual, country-level experts (major markets) familiar with individual country regulations
About
Mark has specialized in access programs for over 12 years and leads Medicines Access.
About
With over 20 years of industry experience, Stuart leads the consulting arm of our Medicines Access team.
About
With 20 years experience in the pharmaceutical industry, Ruth leads the implementation of our pre-approval access programs.
About
Kelly has 25 experience in regulatory affairs and quality assurance, 10 of which specializing in Medicines Access regulations
Inceptua Group Expands Early Access Program to Latin America
Conference attendance: Meet Inceptua Early Access & Unlicensed Medicines 2024
Typically, there are three ways in which patients can get access to a medicine; through a clinical trial, when it is commercially available, or via
The regulations governing earlyl access (expanded access, compassionate use, named patient supply etc.) are constantly being
